Also, serum and urinary APEX1 levels in bladder cancer patients of the late-stage were significantly higher than those in the early stage, and APEX1 level in the sera of muscle-invasive bladder cancer patients was higher than that in non-muscle invasive bladder cancer patients [20,21]. This evidence concerns the gene APEX1 and urinary bladder cancer.